Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Drug Safety: Improvement Needed in FDA's Postmarket Decision-making and Oversight Process. GAO-06-402. Washington, DC, 2006. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-06-402.
Government Accountability Office. (2006, March 31). GAO-06-402 - Drug Safety: Improvement Needed in FDA's Postmarket Decision-making and Oversight Process. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-06-402
Government Accountability Office. GAO-06-402 - Drug Safety: Improvement Needed in FDA's Postmarket Decision-making and Oversight Process. U.S. Government Printing Office, (31 Mar 2006), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-06-402
Government Accountability Office, Drug Safety: Improvement Needed in FDA's Postmarket Decision-making and Oversight Process, GovInfo, (March 31, 2006), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-06-402